Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for King Rachel K.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-05-19
Purchase		2021-05-21
5:06 pm		NOVAVAX INCKing Rachel K.
Director		700$139.64$97,7485,000
(Indirect
Direct)		View
2020-12-28
Sale		2020-12-30
4:00 pm		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		84,176$3.91$329,128531,206
(Indirect
Direct)		View
2019-03-27
Purchase		2019-03-28
4:21 pm		NOVAVAX INCKing Rachel K.
Director		86,000$0.5298$45,56364,000
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-06-10
Exercise		2023-06-13
4:46 pm		N/A
N/A		NOVAVAX INCKing Rachel K.
Director		3,100$026,630
(Direct)		View
2023-06-12
Option Award		2023-06-13
4:46 pm		2024-06-12
2033-06-12		NOVAVAX INCKing Rachel K.
Director		14,380$026,630
(Direct)		View
2023-05-19
Option Award		2023-05-22
4:27 pm		N/A
2033-05-18		GLYCOMIMETICS INCGLYCKing Rachel K.
Director		35,000$035,000
(Direct)		View

Ownership		2023-02-06
4:13 pm		N/A
N/A		GLYCOMIMETICS INCGLYCKing Rachel K.
Director		0$0646,597
(Indirect)		View
2022-02-15
Ownership		2023-02-06
4:13 pm		N/A
N/A		GLYCOMIMETICS INCGLYCKing Rachel K.
Director		19,141$0646,597
(Direct)		View
2022-06-17
Exercise		2022-06-21
8:46 pm		N/A
N/A		NOVAVAX INCKing Rachel K.
Director		700$09,150
(Direct)		View
2022-06-10
Option Award		2022-06-14
5:08 pm		2023-06-10
2032-06-10		NOVAVAX INCKing Rachel K.
Director		7,700$07,700
(Direct)		View
2022-05-18
Option Award		2022-05-20
4:16 pm		N/A
2032-05-17		GLYCOMIMETICS INCGLYCKing Rachel K.
Director		21,000$021,000
(Direct)		View
2021-06-25
Exercise(A)		2021-08-20
5:29 pm		N/A
N/A		NOVAVAX INCKing Rachel K.
Director		3,450$09,700
(Direct)		View
2021-06-25
Exercise		2021-06-29
5:14 pm		N/A
N/A		NOVAVAX INCKing Rachel K.
Director		6,900$011,900
(Direct)		View
2021-06-17
Option Award		2021-06-22
5:18 pm		2022-06-17
2031-06-17		NOVAVAX INCKing Rachel K.
Director		2,000$02,000
(Direct)		View
2021-01-20
Option Award		2021-01-22
4:00 pm		N/A
2031-01-19		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		288,750$0819,956
(Direct)		View
2020-12-28
Exercise		2020-12-30
4:00 pm		N/A
2021-01-04		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		130,821$0531,206
(Direct)		View
2020-12-28
Exercise		2020-12-30
4:00 pm		N/A
N/A		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		130,821$1.12531,206
(Direct)		View
2020-06-25
Option Award		2020-06-26
9:18 pm		2021-06-25
2030-06-25		NOVAVAX INCKing Rachel K.
Director		10,350$010,350
(Direct)		View
2020-01-22
Option Award		2020-01-24
4:14 pm		N/A
2030-01-21		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		349,000$0349,000
(Direct)		View
2019-12-12
Option Award		2019-12-16
5:00 pm		2020-12-12
2029-12-12		NOVAVAX INCKing Rachel K.
Director		18,000$018,000
(Direct)		View
2019-08-06
Exercise		2019-08-07
4:29 pm		N/A
2021-01-04		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		166,759$0615,382
(Direct)		View
2019-08-06
Exercise		2019-08-07
4:29 pm		N/A
N/A		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		166,759$1.12615,382
(Direct)		View
2019-01-17
Option Award		2019-01-22
6:22 pm		N/A
2029-01-16		GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO		265,000$0265,000
(Direct)		View
2018-10-31
Option Award		2018-11-02
4:41 pm		2019-10-31
2028-10-31		NOVAVAX INCKing Rachel K.
Director		160,000$0160,000
(Direct)		View
(A) Indicate amendment filing.